Pioneering solutions to save and improve lives
Research is critical to combatting brain disease and improving the lives of those impacted, today and in the future.
Conducted by The Royal Melbourne Hospital’s Departments of Neurology and Neurosurgery, the active research programs and clinical trials supported by the Foundation cover an extensive breadth of neurological conditions.
Patients wishing to participate are encouraged to view the relevant trial and contact the trial co-ordinator for more information.
Sponsors wishing to support clinical trials should contact the Foundation on +61 3 9342 8447 or email neuro.foundation@mh.org.au.
A Phase 3 Placebo-controlled Study of Milvexian after an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack
"A multicenter, international, randomized, placebo controlled, double-blind, parallel group and event driven Phase 3 study of the oral FXIa inhibitor asundexian (BAY 2433334) for the prevention of ischemic stroke in male and female participants aged 18 years and older after an acute non-cardioembolic ischemic
stroke or high-risk TIA"
Safety and Tolerability of Adjunctive TBO-309 in Reperfusion for Stroke
A Phase II, Multicenter, Double Blinded, Randomized, Placebo Controlled, Parallel-Group, Single-Dose Study to Determine the Safety, Preliminary Efficacy,and Pharmacokinetics of ARG 007 in Acute Ischemic Stroke Patients